Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3 -ITD Allelic Ratio

Blood (2014) 124 (21): 323.

https://doi.org/10.1182/blood.V124.21.323.323

Published: 2014

Journal Articles

Poor-Risk Acute Leukemia Patients with An EBMT Low-Risk Score and An 8/8 Matched Unrelated Donor Show Excellent Survival After Hematopoietic Stem Cell Transplantation.

Tom Lodewyck, MD, Machteld Oudshoorn, PhD, Bronno van der Holt, PhD, Eefke Petersen, MD, PhD, Eric Spierings, PhD, Peter A. Von Dem Borne, MD, PhD, Anton Schattenberg, MD, PhD, Wil Allebes, PhD, Ellen Meijer, MD, PhD, Marlies Groenendijk-Sijnke, Lucia Duinhouwer, Roelof Willemze, MD, PhD, Leo F. Verdonck, MD, PhD, Bob Lowenberg, MD, PhD, Jan J. Cornelissen, MD, PhD

Blood (2009) 114 (22): 1196.

https://doi.org/10.1182/blood.V114.22.1196.1196

Published: 2009

Journal Articles

Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myeloid Leukemia Patients Older Than 40 Years.

Cynthia Huisman, MD, PhD, Ellen Meijer, MD, PhD, Eefke J. Petersen, MD, PhD, Henk M. Lokhorst, MD, PhD, Leo F. Verdonck, MD, PhD

Blood (2007) 110 (11): 5074.

https://doi.org/10.1182/blood.V110.11.5074.5074

Published: 2007

Journal Articles

The In Vivo Impact of Human Regulatory T Cells on the Graft Versus Tumor Effect.

Tuna Mutis, MD, PhD, Henk Rozemuller, PhD, Maarten E. Emmelot, Tineke Aarts-Riemens, Vivienne Verweij, Saskia Ebeling, PhD, Leo F. Verdonck, MD, PhD, Henk Lockhorst, MD, PhD, Anton Martens, PhD

Blood (2007) 110 (11): 349.

https://doi.org/10.1182/blood.V110.11.349.349

Published: 2007

Journal Articles

Pulmonary Complications after T-Cell Depleted Allogeneic Stem Cell Transplantation: Low Incidence and Strong Association with Acute GVHD.

Cynthia Huisman, MD, PhD, Hanneke M. van der Straaten, MD, Marijke R. Canninga-van Dijk, MD, Rob Fijnheer, MD, PhD, Leo F. Verdonck, MD, PhD

Blood (2005) 106 (11): 1821.

https://doi.org/10.1182/blood.V106.11.1821.1821

Published: 2005

Journal Articles

Six Courses of Intensified CHOP Plus G-CSF Compared to Eight Courses of Standard CHOP in Patients with Intermediate-Risk Aggressive Non-Hodgkin Lymphoma Results of a Prospective Randomized HOVON Trial.

Leo F. Verdonck, MD, PhD, Gustaaf W. van Imhoff, MD, John M.M. Raemakers, MD, PhD, Gregor Verhoef, MD, PhD, Mark H.H. Kramer, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Jeanette K. Doorduijn, MD, PhD, Ine A.M.H. Meulendijks, MD, PhD, Wessel N. van Wieringen, MD, PhD, Pieter Sonneveld, MD, PhD

Blood (2005) 106 (11): 14.

https://doi.org/10.1182/blood.V106.11.14.14

Published: 2005

Journal Articles

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

Tuna Mutis, MD, PhD, Leo F. Verdonck, MD, PhD, Tineke Aarts-Riemens, Maarten Emmelot

Blood (2005) 106 (11): 3315.

https://doi.org/10.1182/blood.V106.11.3315.3315

Published: 2005

Journal Articles

Induction of Xenogeneic Graft-Versus-Host Disease through Administration of HuPBMC to Immune Deficient RAG2 −/− γc −/− Mice: A Model for B Cell-Involvement in Chronic Graft-Versus-Host Disease.

Marijke C. Canninga-van Dijk, MD, PhD, Rozemarijn S. van Rijn, MD, Elles R. Simonetti, BSc, Marieke C. Hogenes, MD, Saskia Smulders, BSc, Roel A. de Weger, PhD, Anton Hagenbeek, MD, PhD, Jan G. van de Tweel, MD, PhD, Leo F. Verdonck, MD, PhD, Anton C.M. Martens, PhD, Saskia B. Ebeling, PhD

Blood (2005) 106 (11): 3099.

https://doi.org/10.1182/blood.V106.11.3099.3099

Published: 2005

Journal Articles

A Phase I Trial of Dose Escalating Simvastatin Combined with Chemotherapy in End-Stage Myeloma and Lymphoma.

Henk M. Lokhorst, MD, PhD, Niels van de Donk, MD, PhD, Ellen van de Spek, MD, Okke de Weerdt, MD, Rene van de Griend, MD, PhD, Shulamiet Wittebol, MD, Leo F. Verdonck, MD, PhD, Andries C. Bloem, MD, PhD

Blood (2004) 104 (11): 3458.

https://doi.org/10.1182/blood.V104.11.3458.3458

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3 -ITD Allelic Ratio

Poor-Risk Acute Leukemia Patients with An EBMT Low-Risk Score and An 8/8 Matched Unrelated Donor Show Excellent Survival After Hematopoietic Stem Cell Transplantation.

Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myeloid Leukemia Patients Older Than 40 Years.

The In Vivo Impact of Human Regulatory T Cells on the Graft Versus Tumor Effect.

Pulmonary Complications after T-Cell Depleted Allogeneic Stem Cell Transplantation: Low Incidence and Strong Association with Acute GVHD.

Six Courses of Intensified CHOP Plus G-CSF Compared to Eight Courses of Standard CHOP in Patients with Intermediate-Risk Aggressive Non-Hodgkin Lymphoma Results of a Prospective Randomized HOVON Trial.

Generation of CD4 + Regulatory T Cells by Retroviral Transduction of CD4 + CD25 − T Cells Either with the Full-Length or with a Common Exon-2 Negative Variant of Human Foxp3.

Induction of Xenogeneic Graft-Versus-Host Disease through Administration of HuPBMC to Immune Deficient RAG2 −/− γc −/− Mice: A Model for B Cell-Involvement in Chronic Graft-Versus-Host Disease.

A Phase I Trial of Dose Escalating Simvastatin Combined with Chemotherapy in End-Stage Myeloma and Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only